Perspectives of pediatric oncologists on referral for CAR-T therapy: a mixed methods pilot study.

Anurekha G HallDevan M DuenasJenna VoutsinasQian WuAdam J LambleElizabeth GruberBenjamin WilfondJulie R ParkAnurag K AgrawalJonathan M Marron

Published in: JNCI cancer spectrum (2024)

Nearly 40% of oncologists consider nonclinical features significantly influential when deciding to refer patients for CAR-T therapy, raising concern for bias in the referral process. Establishing formal partnerships with CAR-T therapy centers may help address physician barriers in referral.

Keyphrases

primary care
end stage renal disease
emergency department
chronic kidney disease
ejection fraction
randomized controlled trial
study protocol
public health
mesenchymal stem cells
patient reported outcomes